Pharmaceutical firm Astellas has promoted Doug Geiger to vice president and head of new therapeutic areas in marketing strategy.
In his new role, Geiger will oversee the delivery of global strategic commercial leadership on key initiatives within Astellas' emerging therapeutic areas. His direct supervisor will be Yukio Matsui, senior vice president and head of marketing strategy.
"Doug has been a pivotal strategic commercial leader since joining Astellas in 2008," said Matsui. "He will play an instrumental role as we establish a presence in new therapeutic focus areas such as pain, central nervous system, nephrology and inflammation."
Geiger has 23 years of experience in the pharmaceutical industry. He came to Astellas in 2008 as director of new product planning in the U.S., and was instrumental in the development of the company's oncology business unit.
Geiger has been Astellas' senior director and head of the new product planning in the U.S. since 2012. He earned a bachelor of science degree in finance from the University of Illinois, a master of science in accounting from DePaul University's Kellstadt Graduate School of Business, and an MBA from Northwestern University's Kellogg School of Management.
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.